Physician profile
Hung Q Dam
NPI 1053374181
$4,228.73
in general payments reported to CMS, 2019-2025
19 companies · $2,233 in 2025
The $2,233 reported for 2025 was more than what 87% of Nuclear Medicine providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $449 · 2020: $39.39 · 2021: $52.53 · 2022: $84.44 · 2023: $467 · 2024: $904 · 2025: $2,233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,412 · Consulting Fee: $700 · Travel and Lodging: $491.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,412.31 |
| Consulting Fee | $700.00 |
| Travel and Lodging | $491.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Telix Pharmaceuticals | $1,008.77 | 2024-2025 | Illuccix |
| Boston Scientific Corporation | $851.08 | 2025 | General - Therapies, Therasphere Y90 Glass Microspheres 10 Gbq |
| Ge Healthcare | $491.16 | 2021-2025 | |
| Progenics Pharmaceuticals, INC. | $405.88 | 2023-2025 | Pylarify |
| Pfizer INC. | $351.00 | 2023-2025 | |
| Amgen INC. | $231.27 | 2019 | |
| Daxor Corporation | $141.06 | 2023 | Bva-100 |
| Sirtex Medical INC | $130.86 | 2020-2025 | Sir-Spheres Microspheres |
| Bayer Healthcare Pharmaceuticals INC. | $109.78 | 2023-2025 | |
| Advanced Accelerator Applications | $104.25 | 2019 | |
| Kite Pharma, INC. | $99.00 | 2019 | |
| Lilly USA, LLC | $91.89 | 2024 | |
| Novartis Pharmaceuticals Corporation | $85.80 | 2023-2025 | |
| Astrazeneca Pharmaceuticals Lp | $29.77 | 2024 | Wainua |
| Blue Earth Diagnostics | $24.12 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curium US LLC | $20.15 | 2025 | Detectnet |
| Trisalus Life Sciences, INC. | $20.10 | 2023 | Trinav Infusion System |
| Siemens Medical Solutions USA, INC. | $18.59 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $14.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hung Dam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.